Drug Shortage Report for PMS-NITROFURANTOIN BID
Report ID | 214346 |
Drug Identification Number | 02455676 |
Brand name | PMS-NITROFURANTOIN BID |
Common or Proper name | NITROFURANTOIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NITROFURANTOIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01XE |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-22 |
Estimated end date | 2024-02-20 |
Actual end date | 2024-02-21 |
Shortage status | Resolved |
Updated date | 2024-02-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-28 | French | Compare |
v3 | 2024-02-28 | English | Compare |
v2 | 2023-12-27 | French | Compare |
v1 | 2023-12-27 | English | Compare |
Showing 1 to 4 of 4